Grown Rogue International Inc.

PCNY Operating Platform

The Hamptonburgh production facility includes approximately 24,000 square feet of indoor flower canopy, 16,000 square feet of light-deprivation greenhouse flower canopy, and significant manufacturing and post-harvest infrastructure, including ethanol and hydrocarbon extraction capabilities and a commercial kitchen. PCNY's Verilife dispensaries include two combination adult-use and medical locations in metropolitan Albany and Syracuse and two medical-only locations in metropolitan Buffalo and New York City (Bronx).

Before substantially slowing production in early 2026, the Hamptonburgh facility was producing more than 2,000 lbs of flower a month on average. The four dispensaries have been averaging aggregate monthly sales of $1.7-2.0 million over the past eighteen months. Historical revenue for PCNY was disproportionately through the medical channel, with dispensary revenue skewed to first-party products. Approximately 80% of PCNY's wholesale revenue was attributable to flower and pre-roll products.

In addition to ramping production in Hamptonburgh, GRNY will immediately begin managing PCNY's four dispensaries under the GSA during the interim period. The dispensaries may experience modest disruption as the production slowdown in Hamptonburgh translates to less first-party product availability and brand continuity. Grown Rogue anticipates a six-to-nine month ramp in production at Hamptonburgh.